nodes	percent_of_prediction	percent_of_DWPC	metapath
Oritavancin—Abscess—Betamethasone—atopic dermatitis	0.00529	0.00529	CcSEcCtD
Oritavancin—Immune system disorder—Loratadine—atopic dermatitis	0.00522	0.00522	CcSEcCtD
Oritavancin—Tachycardia—Dimenhydrinate—atopic dermatitis	0.0052	0.0052	CcSEcCtD
Oritavancin—Tachycardia—Diphenhydramine—atopic dermatitis	0.0052	0.0052	CcSEcCtD
Oritavancin—Pruritus—Desonide—atopic dermatitis	0.00516	0.00516	CcSEcCtD
Oritavancin—Infection—Pimecrolimus—atopic dermatitis	0.00512	0.00512	CcSEcCtD
Oritavancin—Connective tissue disorder—Fluocinolone Acetonide—atopic dermatitis	0.0051	0.0051	CcSEcCtD
Oritavancin—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.00505	0.00505	CcSEcCtD
Oritavancin—Skin disorder—Pimecrolimus—atopic dermatitis	0.005	0.005	CcSEcCtD
Oritavancin—Extravasation—Dexamethasone—atopic dermatitis	0.0048	0.0048	CcSEcCtD
Oritavancin—Extravasation—Betamethasone—atopic dermatitis	0.0048	0.0048	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Pimecrolimus—atopic dermatitis	0.00469	0.00469	CcSEcCtD
Oritavancin—Mediastinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00468	0.00468	CcSEcCtD
Oritavancin—Abscess—Prednisone—atopic dermatitis	0.00461	0.00461	CcSEcCtD
Oritavancin—Rash—Desonide—atopic dermatitis	0.0046	0.0046	CcSEcCtD
Oritavancin—Dermatitis—Desonide—atopic dermatitis	0.00459	0.00459	CcSEcCtD
Oritavancin—Angioedema—Loratadine—atopic dermatitis	0.00459	0.00459	CcSEcCtD
Oritavancin—Headache—Desonide—atopic dermatitis	0.00457	0.00457	CcSEcCtD
Oritavancin—Malnutrition—Fluocinolone Acetonide—atopic dermatitis	0.00452	0.00452	CcSEcCtD
Oritavancin—Wheezing—Triamcinolone—atopic dermatitis	0.00448	0.00448	CcSEcCtD
Oritavancin—Immune system disorder—Mometasone—atopic dermatitis	0.00448	0.00448	CcSEcCtD
Oritavancin—Mediastinal disorder—Mometasone—atopic dermatitis	0.00447	0.00447	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.00445	0.00445	CcSEcCtD
Oritavancin—Infestation NOS—Tacrolimus—atopic dermatitis	0.00439	0.00439	CcSEcCtD
Oritavancin—Infestation—Tacrolimus—atopic dermatitis	0.00439	0.00439	CcSEcCtD
Oritavancin—Hypersensitivity—Fluocinonide—atopic dermatitis	0.00435	0.00435	CcSEcCtD
Oritavancin—Myalgia—Loratadine—atopic dermatitis	0.00428	0.00428	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Loratadine—atopic dermatitis	0.00425	0.00425	CcSEcCtD
Oritavancin—Urticaria—Dimenhydrinate—atopic dermatitis	0.00423	0.00423	CcSEcCtD
Oritavancin—Urticaria—Diphenhydramine—atopic dermatitis	0.00423	0.00423	CcSEcCtD
Oritavancin—Pruritus—Fluocinonide—atopic dermatitis	0.00418	0.00418	CcSEcCtD
Oritavancin—Urticaria—Pimecrolimus—atopic dermatitis	0.00409	0.00409	CcSEcCtD
Oritavancin—Nervous system disorder—Loratadine—atopic dermatitis	0.00402	0.00402	CcSEcCtD
Oritavancin—Tachycardia—Loratadine—atopic dermatitis	0.004	0.004	CcSEcCtD
Oritavancin—Skin disorder—Loratadine—atopic dermatitis	0.00399	0.00399	CcSEcCtD
Oritavancin—Angioedema—Mometasone—atopic dermatitis	0.00394	0.00394	CcSEcCtD
Oritavancin—Dizziness—Fluocinonide—atopic dermatitis	0.00391	0.00391	CcSEcCtD
Oritavancin—Oedema peripheral—Tacrolimus—atopic dermatitis	0.00389	0.00389	CcSEcCtD
Oritavancin—Connective tissue disorder—Tacrolimus—atopic dermatitis	0.00388	0.00388	CcSEcCtD
Oritavancin—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.0038	0.0038	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Loratadine—atopic dermatitis	0.00374	0.00374	CcSEcCtD
Oritavancin—Erythema multiforme—Tacrolimus—atopic dermatitis	0.00373	0.00373	CcSEcCtD
Oritavancin—Rash—Fluocinonide—atopic dermatitis	0.00373	0.00373	CcSEcCtD
Oritavancin—Dermatitis—Fluocinonide—atopic dermatitis	0.00372	0.00372	CcSEcCtD
Oritavancin—Headache—Fluocinonide—atopic dermatitis	0.0037	0.0037	CcSEcCtD
Oritavancin—Myalgia—Mometasone—atopic dermatitis	0.00367	0.00367	CcSEcCtD
Oritavancin—Infection—Fluocinolone Acetonide—atopic dermatitis	0.00366	0.00366	CcSEcCtD
Oritavancin—Cardiac disorder—Tacrolimus—atopic dermatitis	0.00366	0.00366	CcSEcCtD
Oritavancin—Diarrhoea—Diphenhydramine—atopic dermatitis	0.00364	0.00364	CcSEcCtD
Oritavancin—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.00364	0.00364	CcSEcCtD
Oritavancin—Pruritus—Pimecrolimus—atopic dermatitis	0.00364	0.00364	CcSEcCtD
Oritavancin—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.00362	0.00362	CcSEcCtD
Oritavancin—Immune system disorder—Tacrolimus—atopic dermatitis	0.00356	0.00356	CcSEcCtD
Oritavancin—Mediastinal disorder—Tacrolimus—atopic dermatitis	0.00355	0.00355	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.00354	0.00354	CcSEcCtD
Oritavancin—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00352	0.00352	CcSEcCtD
Oritavancin—Dizziness—Dimenhydrinate—atopic dermatitis	0.00352	0.00352	CcSEcCtD
Oritavancin—Dizziness—Diphenhydramine—atopic dermatitis	0.00352	0.00352	CcSEcCtD
Oritavancin—Infection—Mometasone—atopic dermatitis	0.0035	0.0035	CcSEcCtD
Oritavancin—Malnutrition—Tacrolimus—atopic dermatitis	0.00343	0.00343	CcSEcCtD
Oritavancin—Vomiting—Dimenhydrinate—atopic dermatitis	0.00339	0.00339	CcSEcCtD
Oritavancin—Vomiting—Diphenhydramine—atopic dermatitis	0.00339	0.00339	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Fluocinolone Acetonide—atopic dermatitis	0.00336	0.00336	CcSEcCtD
Oritavancin—Rash—Dimenhydrinate—atopic dermatitis	0.00336	0.00336	CcSEcCtD
Oritavancin—Rash—Diphenhydramine—atopic dermatitis	0.00336	0.00336	CcSEcCtD
Oritavancin—Dermatitis—Dimenhydrinate—atopic dermatitis	0.00336	0.00336	CcSEcCtD
Oritavancin—Dermatitis—Diphenhydramine—atopic dermatitis	0.00336	0.00336	CcSEcCtD
Oritavancin—Headache—Diphenhydramine—atopic dermatitis	0.00334	0.00334	CcSEcCtD
Oritavancin—Headache—Dimenhydrinate—atopic dermatitis	0.00334	0.00334	CcSEcCtD
Oritavancin—Vomiting—Pimecrolimus—atopic dermatitis	0.00328	0.00328	CcSEcCtD
Oritavancin—Rash—Pimecrolimus—atopic dermatitis	0.00325	0.00325	CcSEcCtD
Oritavancin—Dermatitis—Pimecrolimus—atopic dermatitis	0.00324	0.00324	CcSEcCtD
Oritavancin—Headache—Pimecrolimus—atopic dermatitis	0.00323	0.00323	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Mometasone—atopic dermatitis	0.00321	0.00321	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00318	0.00318	CcSEcCtD
Oritavancin—Anaemia—Tacrolimus—atopic dermatitis	0.00317	0.00317	CcSEcCtD
Oritavancin—Nausea—Dimenhydrinate—atopic dermatitis	0.00316	0.00316	CcSEcCtD
Oritavancin—Nausea—Diphenhydramine—atopic dermatitis	0.00316	0.00316	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Hydrocortisone—atopic dermatitis	0.00314	0.00314	CcSEcCtD
Oritavancin—Nausea—Pimecrolimus—atopic dermatitis	0.00306	0.00306	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Methylprednisolone—atopic dermatitis	0.00295	0.00295	CcSEcCtD
Oritavancin—Myalgia—Tacrolimus—atopic dermatitis	0.00292	0.00292	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.0029	0.0029	CcSEcCtD
Oritavancin—Bronchospasm—Methylprednisolone—atopic dermatitis	0.00284	0.00284	CcSEcCtD
Oritavancin—Diarrhoea—Loratadine—atopic dermatitis	0.00281	0.00281	CcSEcCtD
Oritavancin—Infection—Tacrolimus—atopic dermatitis	0.00278	0.00278	CcSEcCtD
Oritavancin—Nervous system disorder—Tacrolimus—atopic dermatitis	0.00275	0.00275	CcSEcCtD
Oritavancin—Infestation NOS—Hydrocortisone—atopic dermatitis	0.00274	0.00274	CcSEcCtD
Oritavancin—Infestation—Hydrocortisone—atopic dermatitis	0.00274	0.00274	CcSEcCtD
Oritavancin—Tachycardia—Tacrolimus—atopic dermatitis	0.00274	0.00274	CcSEcCtD
Oritavancin—Skin disorder—Tacrolimus—atopic dermatitis	0.00272	0.00272	CcSEcCtD
Oritavancin—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.00272	0.00272	CcSEcCtD
Oritavancin—Dizziness—Loratadine—atopic dermatitis	0.00271	0.00271	CcSEcCtD
Oritavancin—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.00261	0.00261	CcSEcCtD
Oritavancin—Vomiting—Loratadine—atopic dermatitis	0.00261	0.00261	CcSEcCtD
Oritavancin—Rash—Loratadine—atopic dermatitis	0.00259	0.00259	CcSEcCtD
Oritavancin—Dermatitis—Loratadine—atopic dermatitis	0.00258	0.00258	CcSEcCtD
Oritavancin—Infestation NOS—Methylprednisolone—atopic dermatitis	0.00258	0.00258	CcSEcCtD
Oritavancin—Infestation—Methylprednisolone—atopic dermatitis	0.00258	0.00258	CcSEcCtD
Oritavancin—Headache—Loratadine—atopic dermatitis	0.00257	0.00257	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.00255	0.00255	CcSEcCtD
Oritavancin—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00252	0.00252	CcSEcCtD
Oritavancin—Pruritus—Mometasone—atopic dermatitis	0.00249	0.00249	CcSEcCtD
Oritavancin—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00244	0.00244	CcSEcCtD
Oritavancin—Nausea—Loratadine—atopic dermatitis	0.00244	0.00244	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.00242	0.00242	CcSEcCtD
Oritavancin—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.00242	0.00242	CcSEcCtD
Oritavancin—Diarrhoea—Mometasone—atopic dermatitis	0.00241	0.00241	CcSEcCtD
Oritavancin—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00234	0.00234	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.00233	0.00233	CcSEcCtD
Oritavancin—Rash—Fluocinolone Acetonide—atopic dermatitis	0.00232	0.00232	CcSEcCtD
Oritavancin—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.00232	0.00232	CcSEcCtD
Oritavancin—Headache—Fluocinolone Acetonide—atopic dermatitis	0.00231	0.00231	CcSEcCtD
Oritavancin—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.00227	0.00227	CcSEcCtD
Oritavancin—Vomiting—Mometasone—atopic dermatitis	0.00224	0.00224	CcSEcCtD
Oritavancin—Urticaria—Tacrolimus—atopic dermatitis	0.00223	0.00223	CcSEcCtD
Oritavancin—Immune system disorder—Hydrocortisone—atopic dermatitis	0.00222	0.00222	CcSEcCtD
Oritavancin—Rash—Mometasone—atopic dermatitis	0.00222	0.00222	CcSEcCtD
Oritavancin—Dermatitis—Mometasone—atopic dermatitis	0.00222	0.00222	CcSEcCtD
Oritavancin—Headache—Mometasone—atopic dermatitis	0.00221	0.00221	CcSEcCtD
Oritavancin—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00219	0.00219	CcSEcCtD
Oritavancin—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.00215	0.00215	CcSEcCtD
Oritavancin—Malnutrition—Hydrocortisone—atopic dermatitis	0.00214	0.00214	CcSEcCtD
Oritavancin—Nausea—Mometasone—atopic dermatitis	0.00209	0.00209	CcSEcCtD
Oritavancin—Immune system disorder—Methylprednisolone—atopic dermatitis	0.00209	0.00209	CcSEcCtD
Oritavancin—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.00208	0.00208	CcSEcCtD
Oritavancin—Hypersensitivity—Tacrolimus—atopic dermatitis	0.00206	0.00206	CcSEcCtD
Oritavancin—Malnutrition—Methylprednisolone—atopic dermatitis	0.00201	0.00201	CcSEcCtD
Oritavancin—Angioedema—Prednisolone—atopic dermatitis	0.002	0.002	CcSEcCtD
Oritavancin—Pruritus—Tacrolimus—atopic dermatitis	0.00198	0.00198	CcSEcCtD
Oritavancin—Angioedema—Hydrocortisone—atopic dermatitis	0.00196	0.00196	CcSEcCtD
Oritavancin—Diarrhoea—Tacrolimus—atopic dermatitis	0.00192	0.00192	CcSEcCtD
Oritavancin—Dizziness—Tacrolimus—atopic dermatitis	0.00185	0.00185	CcSEcCtD
Oritavancin—Angioedema—Triamcinolone—atopic dermatitis	0.00184	0.00184	CcSEcCtD
Oritavancin—Angioedema—Methylprednisolone—atopic dermatitis	0.00184	0.00184	CcSEcCtD
Oritavancin—Myalgia—Hydrocortisone—atopic dermatitis	0.00182	0.00182	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.00181	0.00181	CcSEcCtD
Oritavancin—Connective tissue disorder—Prednisone—atopic dermatitis	0.0018	0.0018	CcSEcCtD
Oritavancin—Vomiting—Tacrolimus—atopic dermatitis	0.00178	0.00178	CcSEcCtD
Oritavancin—Rash—Tacrolimus—atopic dermatitis	0.00177	0.00177	CcSEcCtD
Oritavancin—Dermatitis—Tacrolimus—atopic dermatitis	0.00177	0.00177	CcSEcCtD
Oritavancin—Headache—Tacrolimus—atopic dermatitis	0.00176	0.00176	CcSEcCtD
Oritavancin—Tachycardia—Prednisolone—atopic dermatitis	0.00175	0.00175	CcSEcCtD
Oritavancin—Infection—Hydrocortisone—atopic dermatitis	0.00174	0.00174	CcSEcCtD
Oritavancin—Myalgia—Triamcinolone—atopic dermatitis	0.00172	0.00172	CcSEcCtD
Oritavancin—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.00171	0.00171	CcSEcCtD
Oritavancin—Myalgia—Methylprednisolone—atopic dermatitis	0.00171	0.00171	CcSEcCtD
Oritavancin—Tachycardia—Hydrocortisone—atopic dermatitis	0.00171	0.00171	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.0017	0.0017	CcSEcCtD
Oritavancin—Skin disorder—Hydrocortisone—atopic dermatitis	0.0017	0.0017	CcSEcCtD
Oritavancin—Angioedema—Dexamethasone—atopic dermatitis	0.00167	0.00167	CcSEcCtD
Oritavancin—Angioedema—Betamethasone—atopic dermatitis	0.00167	0.00167	CcSEcCtD
Oritavancin—Nausea—Tacrolimus—atopic dermatitis	0.00166	0.00166	CcSEcCtD
Oritavancin—Immune system disorder—Prednisone—atopic dermatitis	0.00165	0.00165	CcSEcCtD
Oritavancin—Infection—Triamcinolone—atopic dermatitis	0.00164	0.00164	CcSEcCtD
Oritavancin—Infection—Methylprednisolone—atopic dermatitis	0.00163	0.00163	CcSEcCtD
Oritavancin—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.00161	0.00161	CcSEcCtD
Oritavancin—Tachycardia—Triamcinolone—atopic dermatitis	0.00161	0.00161	CcSEcCtD
Oritavancin—Tachycardia—Methylprednisolone—atopic dermatitis	0.0016	0.0016	CcSEcCtD
Oritavancin—Skin disorder—Methylprednisolone—atopic dermatitis	0.0016	0.0016	CcSEcCtD
Oritavancin—Malnutrition—Prednisone—atopic dermatitis	0.00159	0.00159	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.00159	0.00159	CcSEcCtD
Oritavancin—Myalgia—Dexamethasone—atopic dermatitis	0.00156	0.00156	CcSEcCtD
Oritavancin—Myalgia—Betamethasone—atopic dermatitis	0.00156	0.00156	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.00151	0.00151	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.0015	0.0015	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.0015	0.0015	CcSEcCtD
Oritavancin—Infection—Dexamethasone—atopic dermatitis	0.00148	0.00148	CcSEcCtD
Oritavancin—Infection—Betamethasone—atopic dermatitis	0.00148	0.00148	CcSEcCtD
Oritavancin—Anaemia—Prednisone—atopic dermatitis	0.00147	0.00147	CcSEcCtD
Oritavancin—Nervous system disorder—Betamethasone—atopic dermatitis	0.00146	0.00146	CcSEcCtD
Oritavancin—Nervous system disorder—Dexamethasone—atopic dermatitis	0.00146	0.00146	CcSEcCtD
Oritavancin—Tachycardia—Betamethasone—atopic dermatitis	0.00146	0.00146	CcSEcCtD
Oritavancin—Tachycardia—Dexamethasone—atopic dermatitis	0.00146	0.00146	CcSEcCtD
Oritavancin—Angioedema—Prednisone—atopic dermatitis	0.00146	0.00146	CcSEcCtD
Oritavancin—Urticaria—Prednisolone—atopic dermatitis	0.00142	0.00142	CcSEcCtD
Oritavancin—Urticaria—Hydrocortisone—atopic dermatitis	0.00139	0.00139	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.00136	0.00136	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.00136	0.00136	CcSEcCtD
Oritavancin—Myalgia—Prednisone—atopic dermatitis	0.00136	0.00136	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.00135	0.00135	CcSEcCtD
Oritavancin—Hypersensitivity—Prednisolone—atopic dermatitis	0.00132	0.00132	CcSEcCtD
Oritavancin—Urticaria—Triamcinolone—atopic dermatitis	0.00131	0.00131	CcSEcCtD
Oritavancin—Urticaria—Methylprednisolone—atopic dermatitis	0.0013	0.0013	CcSEcCtD
Oritavancin—Infection—Prednisone—atopic dermatitis	0.00129	0.00129	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.00129	0.00129	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.00129	0.00129	CcSEcCtD
Oritavancin—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.00129	0.00129	CcSEcCtD
Oritavancin—Nervous system disorder—Prednisone—atopic dermatitis	0.00128	0.00128	CcSEcCtD
Oritavancin—Tachycardia—Prednisone—atopic dermatitis	0.00127	0.00127	CcSEcCtD
Oritavancin—Skin disorder—Prednisone—atopic dermatitis	0.00126	0.00126	CcSEcCtD
Oritavancin—Pruritus—Hydrocortisone—atopic dermatitis	0.00124	0.00124	CcSEcCtD
Oritavancin—Hypersensitivity—Triamcinolone—atopic dermatitis	0.00121	0.00121	CcSEcCtD
Oritavancin—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.00121	0.00121	CcSEcCtD
Oritavancin—Diarrhoea—Hydrocortisone—atopic dermatitis	0.0012	0.0012	CcSEcCtD
Oritavancin—Urticaria—Dexamethasone—atopic dermatitis	0.00119	0.00119	CcSEcCtD
Oritavancin—Urticaria—Betamethasone—atopic dermatitis	0.00119	0.00119	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.00119	0.00119	CcSEcCtD
Oritavancin—Dizziness—Prednisolone—atopic dermatitis	0.00118	0.00118	CcSEcCtD
Oritavancin—Pruritus—Triamcinolone—atopic dermatitis	0.00116	0.00116	CcSEcCtD
Oritavancin—Pruritus—Methylprednisolone—atopic dermatitis	0.00116	0.00116	CcSEcCtD
Oritavancin—Dizziness—Hydrocortisone—atopic dermatitis	0.00116	0.00116	CcSEcCtD
Oritavancin—Rash—Prednisolone—atopic dermatitis	0.00113	0.00113	CcSEcCtD
Oritavancin—Dermatitis—Prednisolone—atopic dermatitis	0.00113	0.00113	CcSEcCtD
Oritavancin—Diarrhoea—Methylprednisolone—atopic dermatitis	0.00112	0.00112	CcSEcCtD
Oritavancin—Headache—Prednisolone—atopic dermatitis	0.00112	0.00112	CcSEcCtD
Oritavancin—Vomiting—Hydrocortisone—atopic dermatitis	0.00111	0.00111	CcSEcCtD
Oritavancin—Rash—Hydrocortisone—atopic dermatitis	0.0011	0.0011	CcSEcCtD
Oritavancin—Dermatitis—Hydrocortisone—atopic dermatitis	0.0011	0.0011	CcSEcCtD
Oritavancin—Headache—Hydrocortisone—atopic dermatitis	0.0011	0.0011	CcSEcCtD
Oritavancin—Dizziness—Triamcinolone—atopic dermatitis	0.00109	0.00109	CcSEcCtD
Oritavancin—Dizziness—Methylprednisolone—atopic dermatitis	0.00109	0.00109	CcSEcCtD
Oritavancin—Nausea—Prednisolone—atopic dermatitis	0.00106	0.00106	CcSEcCtD
Oritavancin—Pruritus—Dexamethasone—atopic dermatitis	0.00106	0.00106	CcSEcCtD
Oritavancin—Pruritus—Betamethasone—atopic dermatitis	0.00106	0.00106	CcSEcCtD
Oritavancin—Vomiting—Triamcinolone—atopic dermatitis	0.00105	0.00105	CcSEcCtD
Oritavancin—Vomiting—Methylprednisolone—atopic dermatitis	0.00104	0.00104	CcSEcCtD
Oritavancin—Nausea—Hydrocortisone—atopic dermatitis	0.00104	0.00104	CcSEcCtD
Oritavancin—Rash—Triamcinolone—atopic dermatitis	0.00104	0.00104	CcSEcCtD
Oritavancin—Dermatitis—Triamcinolone—atopic dermatitis	0.00104	0.00104	CcSEcCtD
Oritavancin—Rash—Methylprednisolone—atopic dermatitis	0.00104	0.00104	CcSEcCtD
Oritavancin—Dermatitis—Methylprednisolone—atopic dermatitis	0.00103	0.00103	CcSEcCtD
Oritavancin—Urticaria—Prednisone—atopic dermatitis	0.00103	0.00103	CcSEcCtD
Oritavancin—Headache—Triamcinolone—atopic dermatitis	0.00103	0.00103	CcSEcCtD
Oritavancin—Headache—Methylprednisolone—atopic dermatitis	0.00103	0.00103	CcSEcCtD
Oritavancin—Diarrhoea—Betamethasone—atopic dermatitis	0.00102	0.00102	CcSEcCtD
Oritavancin—Diarrhoea—Dexamethasone—atopic dermatitis	0.00102	0.00102	CcSEcCtD
Oritavancin—Dizziness—Dexamethasone—atopic dermatitis	0.000988	0.000988	CcSEcCtD
Oritavancin—Dizziness—Betamethasone—atopic dermatitis	0.000988	0.000988	CcSEcCtD
Oritavancin—Nausea—Triamcinolone—atopic dermatitis	0.000978	0.000978	CcSEcCtD
Oritavancin—Nausea—Methylprednisolone—atopic dermatitis	0.000976	0.000976	CcSEcCtD
Oritavancin—Hypersensitivity—Prednisone—atopic dermatitis	0.000958	0.000958	CcSEcCtD
Oritavancin—Vomiting—Betamethasone—atopic dermatitis	0.00095	0.00095	CcSEcCtD
Oritavancin—Vomiting—Dexamethasone—atopic dermatitis	0.00095	0.00095	CcSEcCtD
Oritavancin—Rash—Betamethasone—atopic dermatitis	0.000942	0.000942	CcSEcCtD
Oritavancin—Rash—Dexamethasone—atopic dermatitis	0.000942	0.000942	CcSEcCtD
Oritavancin—Dermatitis—Dexamethasone—atopic dermatitis	0.000941	0.000941	CcSEcCtD
Oritavancin—Dermatitis—Betamethasone—atopic dermatitis	0.000941	0.000941	CcSEcCtD
Oritavancin—Headache—Betamethasone—atopic dermatitis	0.000936	0.000936	CcSEcCtD
Oritavancin—Headache—Dexamethasone—atopic dermatitis	0.000936	0.000936	CcSEcCtD
Oritavancin—Pruritus—Prednisone—atopic dermatitis	0.00092	0.00092	CcSEcCtD
Oritavancin—Diarrhoea—Prednisone—atopic dermatitis	0.00089	0.00089	CcSEcCtD
Oritavancin—Nausea—Betamethasone—atopic dermatitis	0.000887	0.000887	CcSEcCtD
Oritavancin—Nausea—Dexamethasone—atopic dermatitis	0.000887	0.000887	CcSEcCtD
Oritavancin—Dizziness—Prednisone—atopic dermatitis	0.00086	0.00086	CcSEcCtD
Oritavancin—Vomiting—Prednisone—atopic dermatitis	0.000827	0.000827	CcSEcCtD
Oritavancin—Rash—Prednisone—atopic dermatitis	0.00082	0.00082	CcSEcCtD
Oritavancin—Dermatitis—Prednisone—atopic dermatitis	0.000819	0.000819	CcSEcCtD
Oritavancin—Headache—Prednisone—atopic dermatitis	0.000815	0.000815	CcSEcCtD
Oritavancin—Nausea—Prednisone—atopic dermatitis	0.000773	0.000773	CcSEcCtD
